network. experience. benefit.

Referenten

 

Wie immer auf dem Pharma-Kongress diskutieren Sie die aktuellen Trends und Herausforderungen mit Referenten aus den führenden europäischen Pharma-Unternehmen, aus Behörden sowie von Universitäten.

Referenten des Pharma-Kongresses 2018:

  • Dr. Gunther Bechmann, Pfizer
    Senior Manager Production Services.
  • Dr. Matthias Beck, Oncotec Pharma Produktion
    Manager New Business Development, verantwortlich für die Entwicklung neuer Produkte und die Überführung in die Produktion.
  • Martin Bergen, securPharm
    General Manager of securPharm e.V.
  • Christoph Bohn, Rommelag CMO - Holopack Verpackungstechnik
    Senior Technical Manager. Verantwortet außerdem als Director Rommelag Pharma Service die weltweite Dienstleistung im Bereich Planung, Consulting und Qualifizierung.
  • Gerald Bürkle, Vetter Pharma-Fertigung
    Vice President Production.
  • Dr. Martin Bultmann, Abbvie
    Head of the NBE Process Engineering Sciences Group in Ludwigshafen.
  • Dr. Lorenzo Capretto, GlaxoSmithKline, Great Britain
    Investigator.
  • Dr. Olivier Chancel, Merial
    Head of Performance and Pharmaceutical Support in Boehringer Ingelheim.
  • Patricia Desmaries, Sanofi Pasteur
    Technical Manager Aseptic Engineering.
  • Dr. Giustino Di Pretoro, Johnson & Johnson
    Associate Director Drug Product Development - Continuous Manufacturing.
  • James Drinkwater, The Pharmaceutical & Healthcare Sciences Society
    Chairman of PHSS.
  • Nikolaus Ferstl, Universitätsklinik Regenburg
    Technischer Leiter der Universitätsklinik und der Universität Regensburg und freier Berater für Gebäude- und Reinraumtechnik.
  • Klaus Feuerhelm, GMP-Inspektor, Regierungspräsidium Tübingen
    Apotheker und pharmazeutischer Referent beim Regierungspräsidium Tübingen.
  • Jasmin Franz, Vetter Pharma-Fertigung
    Innovation Manager for Vetter Pharma-Fertigung.
  • Dr. Rainer Gnibl, Local Authority District Upper Bavaria
    GMP Inspektor für die Regierung von Oberbayern und für die European Medicines Agency (EMA). Außerdem Stellv. Leiter der bundesweiten Expertenfachgruppe „Inspektionen, GMP-Leitfaden“ (EFG 2) bei der ZLG.
  • Dr. Friedrich Haefele, Boehringer Ingelheim Pharma
    Vice President Biopharma Fill & Finish Germany.
  • Andreas Hänel, R-Pharm Germany
    Head of Manufacturing Manager OSD.
  • Dr. Stephan Heck, DSM Nutritional Products
    Senior Director Customer Quality Management.
  • Verena Jachmann, Fresenius Kabi Deutschland
    Head QM/QS Fresenius Kabi Site in Neufahrn.
  • Dr. Gerhard Jas, Corden Pharma
    R&D Management Corden Pharma International.
  • Dr. Jakob Karner, Octapharma
    Head of Corporate PMO – verantwortlich für globale Investitionsprojekte.
  • Dr. Christoph Korpus, Merck
    Leading the Liquid Formulation Stability Laboratory.
  • Dr. Johannes Krämer, CSL Behring
    Leiter des Engineerings.
  • Dr. Lars Kreye, Boehringer Ingelheim Pharma
    Managing two aseptic filling lines (conventional clean room, vial filling), and one isolator line, as well as a packaging unit for final packaging.
  • Arjan Langen, MSD Animal Health
    Pharmaceutical Specialist.
  • Nick Lee, Health Product Regulatory Agency (HPRA), Ireland
    Executive Pharmaceutical Assessor.
  • Dr. Bernd Maier, Merck
    Senior Project Manager.
  • Dr. Jean-Denis Mallet, ECA & Former Head of the French Pharmaceutical Inspection Dpt. AFSSAPS
    Member of the ECA Advisory Board and works for NNE Pharmaplan.
  • Maria Mariño, Abbott, Uruguay
    QA Manager for suppliers.
  • Brett Marshall, Zuellig Pharma, Singapore
    Corporate Head of Quality Assurance.
  • Dr. Eric Meier, Novartis
    Head QA Continuous Manufacturing.
  • Ana Isabel Mendes Alves, GenIbet Biopharmaceuticals
    Bioprocess Specialist.
  • Rudi Meurs, Mithra Pharmaceuticals
    Head of Mithra Pharmaceuticals Contract Development and Manufacturing Organisation (CDMO).
  • Didier Meyer, DMCompliance
    Consultant.
  • Yves Michon, Corden Pharma
    Managing Director, CordenPharma Chenôve.
  • Gerd Moelgaard, Moelgaard Consulting
    Chairman of the ECA Validation interest group.
  • Dr. Ralf Möwes, esparma Pharma Services
    Deputy Head of the Quality Unit and QP.
  • Dr. Daniel Müller, Local Authority of Baden-Württemberg
    GMP Inspector.
  • Dr. Beate Reutter, Landesamt für soziale Dienste Schleswig-Holstein
    GMDP Inspector and head of the inspectorate.
  • Ute Schleyer, Vetter Pharma-Fertigung
    Project Manager, Site & Plant Development.
  • Thorsten Schlosser, Allergopharma
    Vice President TechnicalOPerations.
  • Tobias Schlögl, Vetter Pharma-Fertigung
    Project Manager (customer projects).
  • Dr. Andreas Schreiner, Novartis Pharma
    Head of Solid Dosage Forms.
  • Roland Schuhwerk, Johnson & Johnson / Cilag
    Director Project Engineering Global Technical Services.
  • Dr. Martin Schwab, Vetter Pharma-Fertigung
    Team Lead, Customer Project Management Department.
  • Dr. Thomas Schwarz, Novartis
    Head Strategic Planning and PMO at the Novartis Stein Site for Steriles.
  • Alexandra Stärk, Novartis Pharma
    Head of Microbial Expert Group - Technical Steward Sterility Assurance.
  • Dr. Harald Stahl, GEA
    Group Director Application & Strategy Management.
  • Dr. Frank Thielmann, Novartis
    Operation Excellence Leader Biologics.
  • Calvin Tsai, Orient Pharma Nano
    CEO.
  • Michael Unbehaun, R-Pharm Germany
    Manager Engineering Site Projects & Business Development.
  • Patrick Vanhecke, GSK Vaccines
    Expert in Isolator and Aseptic Filling Technologies and Room decontamination process.
  • Dr. Jean-Pascal Zambaux, AMATSIGROUP Disposable-Lab
    Directeur Général / Pharmacien Responsable.